Yuanfei Pet: The company's overseas sales revenue and profits are on the rise. On December 9, Yuanfei Pet said that at present, the company maintains a good development trend and we have great confidence in the future market development at home and abroad. Since the beginning of this year, due to the continuous increase in the demand of the pet industry and the continuous rise in the company's comprehensive competitiveness, the sales revenue and profit realization of the company's overseas sales have shown an upward trend. At present, the company has put into production a total of four production bases, and has two production bases in Pingyang, Wenzhou, which are equipped with many production lines such as pet snacks, pet traction appliances and pet toys. There are two production bases in Cambodia, namely, Aitao, Cambodia, which focuses on pet food, and Ryder, Cambodia, which focuses on pet products. In the second half of this year, Ryder, Cambodia added a new pet toy production line. In addition, factories in Bangladesh and China are under construction.The Hang Seng Index of Hong Kong stocks opened higher by 3.21%, the index of state-owned enterprises rose by 3.46%, and the branch index rose by 4.24%.The film and television cinema sector went up, Aofei Entertainment went up, and Aofei Entertainment went up. Bona Film had previously closed the board, and Happiness Blue Ocean rose by more than 10%. Huanrui Century, Baina Qiancheng, Huayi Brothers, Hengdian Film and Television, and Jebsen shares followed suit.
The yen fell to a low point against the US dollar since November 29, which cooled down around the expectation of the Bank of Japan to raise interest rates this month. As the market expected the Bank of Japan to raise interest rates this month, the yen fell to its lowest level against the US dollar since the end of November. The yen once fell 0.2% against the US dollar to 151.55. Overnight index swap pricing shows that the probability of the Bank of Japan raising interest rates in December is 28%.Chengyitong: The layout of the company's brain-computer interface business is mainly divided into non-invasive and invasive. Chengyitong (300430) responded to an investor's question on the interactive platform on December 10, saying that the company is also very concerned about Musk's experimental progress and technological breakthrough in brain-computer interface. The company's brain-computer interface business direction layout is mainly divided into non-invasive and invasive. In the non-invasive aspect, the company is mainly committed to integrating brain-computer interface technology with Long Zhijie's existing rehabilitation products to realize the functional upgrade of existing rehabilitation products; In the invasive aspect, the project of "Brain-computer Interface Implantable Biological Laboratory" jointly established by Naolian Technology and Daxing Medical Base Management Committee is being actively promoted. At present, the above business has not generated any income. If progress is made, the company will disclose it in strict accordance with the requirements of laws and regulations.Hong Kong stocks rose by 87% on the first day of listing in Mao Geping, with a turnover of nearly HK$ 1.9 billion.
Trump nominated Kennedy Jr., and 77 Nobel laureates boycotted it. President-elect Trump recently nominated Robert Francis Kennedy Jr. Jr. as the Secretary of the Department of Health and Human Services (HHS), which caused great controversy in the United States. Seventy-seven Nobel laureates in the fields of medicine, chemistry, economics and physics signed a letter urging senators not to approve the nomination of Kennedy Jr. George W. Robert Kennedy is the nephew of former President Kennedy.Topcon is reported to have received an offer from KKR and EQT.The computer equipment sector rose short-term, Shensi Electronics rose daily, and Zhiwei Intelligent, Tonghui Information, Dahua Intelligent, Rotating Pole Information and Zhaori Technology followed suit.
Strategy guide
12-13
Strategy guide
12-13
Strategy guide
12-13
Strategy guide 12-13